Select edition
Country
Primary focus
Medical condition
Organization type
Stakeholder
Quality
Third Edition BOGP (10)
United States (2)
Research
Pharmaceutical Company (9)
Payers (usually governmental or public bodies, reimbursement)
Transparency in communication and documentation
Clinical study phase III